MDMA-assisted therapy and psilocybin-assisted therapy are now available in Australia under strict controls. MDMA-AT can be used for the treatment of PTSD and psilocybin-AT can be used for treatment-resistant depression.
Delivery of these treatments is restricted to psychiatrists who have received approval from the Therapeutic Goods Administration (TGA) as part of their Authorised Prescriber (AP) program.
Availability is currently limited as this program is in its infancy. Please fill out the form below if you are interested in being kept up to date as the field develops. Please note: filling this form does not guarantee treatment for any condition.